Citius Pharmaceuticals (CTXR) Long-Term Deferred Tax (2014 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Long-Term Deferred Tax came in at $169252.0 in Q1 2026, down 99.52% on a QoQ basis from $35.0 million in Q3 2023.
Citius Pharmaceuticals (CTXR) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 10 years of Long-Term Deferred Tax data on file, last reported at $169252.0 in Q1 2026.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $169252.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $169252.0 (changed N/A YoY) and the FY2023 annual result came in at $35.0 million, up 0.89% from the prior year.
- Long-Term Deferred Tax eased to $169252.0 in Q1 2026, from $35.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $35.0 million in Q3 2023 to a low of $169252.0 in Q1 2026.
- A 3-year average of $23.3 million and a median of $34.7 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax jumped 35.93% — and 2023, when it grew 0.89%.
- Tracing CTXR's Long-Term Deferred Tax over 3 years: stood at $34.7 million in 2022, then climbed by 0.89% to $35.0 million in 2023, then plunged by 99.52% to $169252.0 in 2026.
- The last three Long-Term Deferred Tax figures came in at $169252.0 (Q1 2026), $35.0 million (Q3 2023), and $34.7 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,252.00 |
| Sep 30, 2023 | 34.98 Mn |
| Sep 30, 2022 | 34.67 Mn |
| Sep 30, 2021 | 25.51 Mn |
| Sep 30, 2020 | 14.50 Mn |
| Sep 30, 2019 | 10.99 Mn |
| Sep 30, 2018 | 8.96 Mn |
| Sep 30, 2016 | 3.80 Mn |
| Sep 30, 2015 | 1.13 Mn |
| Sep 30, 2014 | 27,000.00 |